Africure Pharmaceuticals, has gone one step further than Goodstrain, by manufacturing pharmaceuticals in Africa.

The company, only founded in 2017, already has nine manufacturing facilities in Africa, employing 300 people across Cameroon, Namibia, Botswana and Côte d’Ivoire, with plans to build plants in Ethiopia and Zimbabwe.

Africure’s factories make medications to treat pain, fever, inflammation, malaria, diabetes andhypertension, as well as a wide range of antibiotics.

“Africa over the years has been dependent on imports of medication from Europe, India, and China, which has resulted in the draining of precious foreign exchange, non-creation of job opportunities, and suffering the vagaries of supply and demand,” says Sinhue Noronha, founder and chief executive of Africure Pharmaceuticals.

Originally from Mumbai, Mr Noronha, hopes his firm will help tackle some of the problems in African healthcare.

“Our primary objective is to solve the persistent issues such as affordability, availability, low quality, technological dependence, and reliance on imports.

“All of our plants and distribution setups are engaged primarily to provide an uninterrupted supply of essential medicines.”